NVSI-06-08

recombinant COVID-19 vaccine (CHO cells) · National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NVSI-06-08, covering 2023-02-01 to 2023-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above [Phase 1, Phase 2]

See pricing